ScoreComparison
Why is Fulgent Genetics, Inc. ?
1
Flat results in Jun 25
- INTEREST(HY) At USD 0.03 MM has Grown at 287.5%
- OPERATING CASH FLOW(Y) Lowest at USD -25.09 MM
- EPS(Q) Lowest at USD -0.62
2
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 68.30%, its profits have risen by 40%
3
High Institutional Holdings at 62.67%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating Performance
- The stock has generated a return of 68.30% in the last 1 year, much higher than market (S&P 500) returns of 12.33%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Fulgent Genetics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Fulgent Genetics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Fulgent Genetics, Inc.
44.76%
1.09
47.40%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
47.28%
EBIT Growth (5y)
-308.85%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.25
Tax Ratio
15.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
62.67%
ROCE (avg)
43.94%
ROE (avg)
17.45%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.58
EV to EBIT
-4.67
EV to EBITDA
-7.04
EV to Capital Employed
0.41
EV to Sales
1.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.87%
ROE (Latest)
-2.82%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET PROFIT(HY)
Higher at USD -20.56 MM
RAW MATERIAL COST(Y)
Fallen by -15.44% (YoY
NET SALES(Q)
Highest at USD 81.8 MM
-8What is not working for the Company
INTEREST(HY)
At USD 0.03 MM has Grown at 287.5%
OPERATING CASH FLOW(Y)
Lowest at USD -25.09 MM
EPS(Q)
Lowest at USD -0.62
Here's what is working for Fulgent Genetics, Inc.
Net Profit
Higher at USD -20.56 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
Highest at USD 81.8 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Raw Material Cost
Fallen by -15.44% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Fulgent Genetics, Inc.
Interest
At USD 0.03 MM has Grown at 287.5%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Cash Flow
Lowest at USD -25.09 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
EPS
Lowest at USD -0.62
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
